Prostate Cancer - Results from #28320

VMAT vs. 7-field-IMRT: Assessing the dosimetric parameters of prostate cancer treatment with a 292-patient sample - Abstract March 30, 2011

Robotic radical prostatectomy: A critical analysis of surgical quality - Abstract March 30, 2011

The role of PET/computed tomography scan in the management of prostate cancer - Abstract March 30, 2011

Metabolomics: A novel approach to early and noninvasive prostate cancer detection - Abstract March 30, 2011

Advances in magnetic resonance imaging: How they are changing the management of prostate cancer - Abstract March 29, 2011

Stromal cell-derived factor-1 and vascular endothelial growth factor as biomarkers for lymph node metastasis and poor cancer-specific survival in prostate cancer patients after radical prostatectomy - Abstract March 29, 2011

Association of prostate cancer risk loci with disease aggressiveness and prostate cancer-specific mortality - Abstract March 29, 2011

A two-step toward personalized therapies for prostate cancer - Abstract March 29, 2011

The association between diffusion of the surgical robot and radical prostatectomy rates - Abstract March 29, 2011

Imaging in prostate cancer diagnosis: Present role and future perspectives - Abstract March 29, 2011

High perceived stress is linked to afternoon cortisol levels and greater symptom distress in patients with localized prostate cancer - Abstract March 29, 2011

Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC) - Abstract March 29, 2011

CURy 2011 - A multidisciplinary team approach to metastatic hormone-refractory prostate cancer treatment - Slide Presentation March 29, 2011

Researchers find many elderly men are undergoing unnecessary PSA screenings March 29, 2011

Use of testosterone replacement therapy in patients with prostate cancer - Abstract March 28, 2011

Prostate-specific antigen for treatment monitoring - Abstract March 28, 2011

The association between radiographic response and overall survival in men with metastatic castration-resistant prostate cancer receiving chemotherapy - Abstract March 28, 2011

Preoperative hypogonadism is not an independent predictor of high-risk disease in patients undergoing radical prostatectomy - Abstract March 28, 2011

Utilization and expense of adjuvant cancer therapies following radical prostatectomy - Abstract March 28, 2011

Steps in prostate cancer progression that lead to bone metastasis - Abstract March 28, 2011

Page 1417 of 1434